Polr2a Phenotype Annotations - Multigenic Genotypes

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Polr2a
polymerase (RNA) II (DNA directed) polypeptide A
MGI:98086

69 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Braf^tm1Mmcm/Braf⁺ Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ involves: 129P2/OlaHsd * C57BL/6 * SJL	increased lung adenoma incidence	J:121715
Braf^tm1Sva/Braf^tm1Sva Kras^tm1Bbd/Kras⁺ Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ	decreased cell proliferation	J:172200
Braf^tm1Sva/Braf^tm1Sva Kras^tm1Bbd/Kras⁺ Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} Raf1^tm2Bacc/Raf1^tm2Bacc involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ	decreased cell proliferation	J:172200
Braf^tm1Sva/Braf^tm1Sva Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} Raf1^tm2Bacc/Raf1^tm2Bacc involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ	no abnormal phenotype detected	J:172200
Cdc20^tm1.1Mama/Cdc20^tm1.2Mama Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL	abnormal epidermis stratum basale morphology	J:167609
	abnormal intestinal epithelium morphology	J:167609
	abnormal mitosis	J:167609
	decreased cell proliferation	J:167609
	decreased tumor growth/size	J:167609
	delayed hair regrowth	J:167609
	premature death	J:167609
	tumor regression	J:167609
	weight loss	J:167609
Cdk2^tm1Sgo/Cdk2^tm1Sgo Kras^tm1Bbd/Kras⁺ Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ	decreased tumor incidence	J:161780
	premature death	J:161780
Cdk2^tm2Sgo/Cdk2^tm2Sgo Cdk4^tm2.1Bbd/Cdk4^tm2.1Bbd Polr2a^{tm1(cre/ERT2)Bbd}/? involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL	decreased body size	J:125217
	normal hematopoietic system phenotype	J:125217
	increased susceptibility to autoimmune diabetes	J:125217
	normal liver/biliary system phenotype	J:125217
Cdk2^tm2Sgo/Cdk2^tm2Sgo Kras^tm1Bbd/Kras^tm2Bbd Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ	decreased tumor incidence	J:161780
	premature death	J:161780
Cdk4^tm2.1Bbd/Cdk4^tm2.1Bbd Kras^tm1Bbd/Kras^tm2Bbd Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ	decreased cell proliferation	J:161780
	decreased tumor growth/size	J:161780
	early cellular replicative senescence	J:161780
	increased adenocarcinoma incidence	J:161780
Cdk4^tm2.2Bbd/Cdk4^tm2.1Bbd Kras^tm1Bbd/Kras^tm2Bbd Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ	decreased cell proliferation	J:161780
	decreased tumor growth/size	J:161780
	decreased tumor incidence	J:161780
	early cellular replicative senescence	J:161780
	increased tumor incidence	J:161780
Cdk4^tm2.2Bbd/Cdk4^tm2.2Bbd Kras^tm1Bbd/Kras^tm1Bbd Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ	decreased tumor incidence	J:161780
Cdk6^tm1Bbd/Cdk6^tm1Bbd Kras^tm1Bbd/Kras⁺ Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ	increased adenoma incidence	J:161780
	increased lung non-small cell carcinoma incidence	J:161780
	premature death	J:161780
Cdkn2a^tm1Rdp/Cdkn2a^tm1Rdp E4f1^tm1Pisc/E4f1^tm1.1Llca Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ involves: 129/Sv * 129S4/SvJae * C57BL/6 * SJL	abnormal keratinocyte physiology	J:167157
	epidermal hyperplasia	J:167157
	hyperkeratosis	J:167157
E4f1^tm1Pisc/E4f1^tm1.1Llca Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ involves: 129S4/SvJae * C57BL/6 * SJL	abnormal hair follicle bulge morphology	J:167157
	abnormal keratinocyte physiology	J:167157
	abnormal skin condition	J:167157
	abnormal skin morphology	J:167157
	abnormal skin physiology	J:167157
	absent epidermis stratum granulosum	J:167157
	absent suprabasal layer	J:167157
	alopecia	J:167157
	epidermal hyperplasia	J:167157
	hyperkeratosis	J:167157
	impaired wound healing	J:167157
	spontaneous skin ulceration	J:167157
	thick skin	J:167157
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ involves: C57BL/6 * SJL	abnormal germinal center B cell physiology	J:182210
	arrested B cell differentiation	J:182210
	decreased B cell proliferation	J:182210
	decreased germinal center B cell number	J:182210
	decreased IgG1 level	J:182210
	decreased IgG3 level	J:182210
	decreased immature B cell number	J:182210
	decreased marginal zone B cell number	J:182210
	decreased pre-B cell number	J:182210
	decreased spleen germinal center number	J:182210
	decreased transitional stage B cell number	J:182210
	normal immune system phenotype	J:182210
	increased B cell apoptosis	J:182210
	increased B cell number	J:182210
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ Tg(BCL2)#Wehi/0 involves: C57BL/6 * C57BL/6JWehi * SJL * SJL/JWehi	decreased immature B cell number	J:182210
	decreased pre-B cell number	J:182210
Fntb^tm1Bbd/Fntb^tm1.1Bbd Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL	abnormal hematopoietic system physiology	J:98944
	decreased cell proliferation	J:98944
	decreased incidence of tumors by chemical induction	J:98944
	delayed wound healing	J:98944
	small spleen	J:98944
Fntb^tm1Bbd/Fntb^tm1Bbd Kras^tm1Bbd/Kras⁺ Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL	increased lung adenocarcinoma incidence	J:98944
	increased lung adenoma incidence	J:98944
Fntb^tm1Bbd/Fntb^tm1Bbd Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL	abnormal hematopoietic system physiology	J:98944
	decreased cell proliferation	J:98944
	decreased incidence of tumors by chemical induction	J:98944
	delayed wound healing	J:98944
	small spleen	J:98944
Kras^tm1Bbd/Kras⁺ Mapk14^tm1Nbr/Mapk14^tm2Nbr Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL	abnormal lung development	J:122397
	abnormal tumor incidence	J:122397
	enlarged lung	J:122397
	increased lung adenocarcinoma incidence	J:122397
	increased lung adenoma incidence	J:122397
	increased lung tumor incidence	J:122397
	premature death	J:122397
Kras^tm1Bbd/Kras⁺ Mapk14^tm2Nbr/Mapk14⁺ Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL	increased hemolymphoid system tumor incidence	J:122397
	increased lung adenoma incidence	J:122397
	increased lung tumor incidence	J:122397
	premature death	J:122397
Kras^tm1Bbd/Kras⁺ Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ	increased adenoma incidence	J:161780
	increased lung non-small cell carcinoma incidence	J:161780
	premature death	J:161780
Kras^tm1Bbd/Kras⁺ Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} Raf1^tm2Bacc/Raf1^tm2Bacc involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ	decreased cell proliferation	J:172200
Kras^tm1Bbd/Kras^tm2Bbd Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129S1/Sv * 129X1/SvJ	increased cell proliferation	J:161780
	increased lung non-small cell carcinoma incidence	J:161780
	increased lung tumor incidence	J:161780
	premature death	J:161780
Map2k1^tm1Chrn/Map2k1^tm1Chrn Map2k2^tm1Chrn/Map2k2^tm1Chrn Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129/Sv * C57BL/6J * SJL	abnormal crypts of Lieberkuhn morphology	J:172200
	abnormal intestine morphology	J:172200
	premature death	J:172200
Mapk1^tm1.1Hed/Mapk1^tm1.1Hed Mapk3^tm1Gpg/Mapk3^tm1Gpg Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} involves: 129	premature death	J:172200
Mapk14^tm1Nbr/Mapk14^tm2Nbr Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL	abnormal lung development	J:122397
	abnormal tumor incidence	J:122397
	enlarged lung	J:122397
	increased lung adenocarcinoma incidence	J:122397
	increased lung adenoma incidence	J:122397
	increased lung tumor incidence	J:122397
	premature death	J:122397
Mapk14^tm2Nbr/Mapk14^tm2Nbr Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ involves: 129 * C57BL/6 * CD-1 * SJL	abnormal cell cycle	J:122397
	abnormal lung epithelium morphology	J:122397
	abnormal lung morphology	J:122397
	abnormal pulmonary alveolus epithelial cell morphology	J:122397
	increased cell proliferation	J:122397
Mastl^tm1.1Mama/Mastl^tm1.1Mama Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ Not Specified	abnormal embryonic neuroepithelium morphology	J:201971
	abnormal mitosis	J:201971
Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ Rnf2^tm1Mvi/Rnf2^tm1Mvi involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * SJL	abnormal bone marrow cell morphology/development	J:130397
	abnormal common myeloid progenitor cell morphology	J:130397
	decreased B cell number	J:130397
Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} Raf1^tm2Bacc/Raf1^tm2Bacc involves: 129P2/OlaHsd	no abnormal phenotype detected	J:172200

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24